Powered By Daylife
Other company news pages:

Merck & Company, Inc. News

Longer-lasting drug co Prolor raises $24.4m: Shai Novik: We raised capital only from investors who want to stick with us for the

...human growth hormone. The trial found that it was possible to give a dosage once every two weeks, instead of daily. Merck & Co. (NYSE: MRK), which uses the CTP peptide in fertility treatments, has obtained certification for its product, Elovna. This approval...

Preventive Medicine: Buying Health Stocks Before Overhaul

...of the $1.3 billion Putnam Global Healthcare Fund (PHSTX), says the diversified global fund's assets are invested based on a company's fundamentals, not by making macro calls on issues such as health-care legislation. But Ms. Chen does see some health-care...

Jades legacy

...licensed, which countries are using it; everything,” said Fikri. Gardasil, manufactured by Merck, is now the German pharmaceutical company’s top-selling vaccine, while Cervarix is made by the British group GlaxoSmithKline. Gardasil protects against four...

Your Health: New methods may boost allergy shots

...and medicine at the University of Tennessee Health Science Center in Memphis. Blaiss, a consultant to the drug's maker, Merck, presented the data at a recent meeting of the American Academy of Allergy, Asthma & Immunology. A study in adults found similar results,...

Nanotech robots deliver gene therapy through blood

...as a key player in the disease process. Dozens of biotechnology and pharmaceutical companies including Alnylam , Merck , Pfizer , Novartis and Roche are looking for ways to manipulate RNA to block genes that make disease-causing...

Industry relationships with physicians are coming under fire

...version of healthcare reform bills. Some pharmaceutical companies — specifically Cephalon, GlaxoSmithKline, Lilly, and Merck — have already begun disclosing lists of payments to physicians on company Web sites, with more companies said to be following suit....

Deadbeat Stock #5: Merck (MRK)

...new drugs, but, in reality, they cannot make up for the lost revenue from Zocor. Merck's (MRK) revenues are stagnant and the company has a very weak pipeline. Even if health care reform adds more patients, it will also bring increased pressure to cut prices. If...

Kilitch Drugs floats new arm for eye-care biz

...contract manufacturing services and supplies to big pharmaceutical firms, including Ranbaxy, Zydus Cadila, Emcure, USV, E-Merck and Piramal Healthcare. It has manufacturing locations at Poanta Sahib in Himachal Pradesh, Navi Mumbai and Thane. - PTI ...

New B+L leadership ready to 'power up'

Schering-Plough Corp. was in trouble. The New Jersey-based pharmaceutical and consumer products company, home of the allergy meds Nasonex and Claritin, was hemorrhaging market share in 2003, seeing its profits fall and facing costly manufacturing and

Longer-lasting drug co Prolor raises $24.4m

...by the body. Prolor has the rights to use the peptide for all indications, except for fertility treatments. During 2009, the company carried out a trial on monkeys of beta interferon drugs for the treatment of multiple sclerosis. The study found that the CTP...

News page is in maintenance. Sorry for the inconvenience.

Clear

Clear

All rights reserved, Nojasa LLC. Copyright, Nojasa LLC.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/